Use of an anti–interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis SG Plötz, HU Simon, U Darsow, D Simon, E Vassina, S Yousefi, R Hein, ... New England Journal of Medicine 349 (24), 2334-2339, 2003 | 289 | 2003 |
Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons ED Nekrasov, VA Vigont, SA Klyushnikov, OS Lebedeva, EM Vassina, ... Molecular neurodegeneration 11, 1-15, 2016 | 172 | 2016 |
Cytokine expression in healthy and inflamed mucosa: probing the role of eosinophils in the digestive tract A Straumann, J Kristl, S Conus, E Vassina, HP Spichtin, C Beglinger, ... Inflammatory bowel diseases 11 (8), 720-726, 2005 | 145 | 2005 |
Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale AA Rizvanov, IV Chestkov, SL Kiselev Cell Cycle 9 (5), 937-946, 2010 | 118 | 2010 |
Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment D Simon, E Vassina, S Yousefi, E Kozlowski, LR Braathen, HU Simon Journal of allergy and clinical immunology 114 (4), 887-895, 2004 | 109 | 2004 |
No DNA damage response and negligible genome-wide transcriptional changes in human embryonic stem cells exposed to terahertz radiation AN Bogomazova, EM Vassina, TN Goryachkovskaya, VM Popik, ... Scientific reports 5 (1), 7749, 2015 | 101 | 2015 |
Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment D Simon, E Vassina, S Yousefi, LR Braathen, HU Simon Allergy 60 (7), 944-951, 2005 | 65 | 2005 |
cIAP‐2 and survivin contribute to cytokine‐mediated delayed eosinophil apoptosis EM Vassina, S Yousefi, D Simon, C Zwicky, S Conus, HU Simon European journal of immunology 36 (7), 1975-1984, 2006 | 61 | 2006 |
Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis E Vassina, M Leverkus, S Yousefi, LR Braathen, HU Simon, D Simon Journal of investigative dermatology 125 (4), 746-752, 2005 | 39 | 2005 |
An integrative analysis of reprogramming in human isogenic system identified a clone selection criterion MV Shutova, AV Surdina, DS Ischenko, VA Naumov, AN Bogomazova, ... Cell Cycle 15 (7), 986-997, 2016 | 32 | 2016 |
Genetic cell reprogramming: a new technology for basic research and applied usage AN Bogomazova, EM Vassina, SL Kiselev, MA Lagarkova, OS Lebedeva, ... Russian Journal of Genetics 51, 386-396, 2015 | 10 | 2015 |
The T348M mutated form of cryopyrin is associated with defective lipopolysaccharide-induced interleukin 10 production in CINCA syndrome T Bihl, E Vassina, MK Boettger, R Goldbach-Mansky, M Seitz, PM Villiger, ... Annals of the rheumatic diseases 64 (9), 1380-1381, 2005 | 9 | 2005 |
Differentiation of human pluripotent stem cells into mesodermal and ectodermal derivatives is independent of the type of isogenic reprogrammed somatic cells ES Philonenko, MV Shutova, SL Kiselev Acta Naturae (англоязычная версия) 9 (1 (32)), 68-74, 2017 | 6 | 2017 |
Immunopharmacological effects of topical tacrolimus in atopic dermatitis D Simon, E Vassina, LR Braathen, HU Simon Journal of Allergy and Clinical Immunology 113 (2), S334, 2004 | 5 | 2004 |
An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease OS Lebedeva, EI Sharova, DA Grekhnev, LO Skorodumova, IV Kopylova, ... International Journal of Molecular Sciences 24 (8), 7297, 2023 | 1 | 2023 |
Reduced number of cytokine-expressing inflammatory cells in AD after topical tacrolimus treatment D Simon, E Vassina, S Yousefi, E Kozlowski, LR Braathen, HU Simon Hogreve & Huber Publishers, 2006 | | 2006 |
Expression and Function of CIAP-2, Survivin and TRAIL in Inflammatory Diseases EM Vassina Verlag nicht ermittelbar, 2005 | | 2005 |
Effects of topical pimecrolimus on skin histology, inflammatory infiltrate and cytokine production in atopic dermatitis D Simon, E Vassina, LR Braathen, HU Simon PHARMACOLOGY 72 (2), 148-148, 2004 | | 2004 |
Differentiation of human pluripotent stem cells into mesodermal and ectodermal derivatives is independent of the type of isogenic reprogrammed somatic cells M Shutova, M Lagarkova, E Philonenko, O Lebedeva, E Vassina, ... | | |
Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons M Ryazantseva, A Skopin, I Chestkov, E Nekrasov, P Bobrovsky, ... | | |